(Q40383231)

20 September 2017

title

Invasive potency related to RCAS1 expression in uterine cervical cancer (English)

1 reference

20 September 2017

Kenzo Sonoda

1

1 reference

20 September 2017

Shingo Miyamoto

2

1 reference

20 September 2017

Toshio Hirakawa

3

1 reference

20 September 2017

Hiroshi Yagi

4

1 reference

20 September 2017

Fusanori Yotsumoto

5

1 reference

20 September 2017

Manabu Nakashima

6

1 reference

20 September 2017

Takeshi Watanabe

7

1 reference

20 September 2017

Hitoo Nakano

8

1 reference

20 September 2017

language of work or name

English

0 references

publication date

1 October 2005

1 reference

20 September 2017

1 reference

20 September 2017

volume

99

1 reference

20 September 2017

issue

1

1 reference

20 September 2017

page(s)

189-198

1 reference

Cancer of the Uterine Cervix

20 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.06.061

Prognostic factors and operative treatment of stages IB to IIB cervical cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.06.061

Pelvic lymph node metastasis of uterine cervical cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.06.061

Multivariate analysis of the histopathologic prognostic factors of cervical cancer in patients undergoing radical hysterectomy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.06.061

Prognostic factors in cervical cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.06.061

Laminin-5 as a marker of invasiveness in cervical lesions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.06.061

Tetranectin and plasmin/plasminogen are similarly distributed at the invasive front of cutaneous melanoma lesions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.06.061

Tumour cell thrombospondin-1 regulates tumour cell adhesion and invasion through the urokinase plasminogen activator receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.06.061

Thrombospondin-1 (TSP-1) promotes the invasive properties of human breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.06.061

Inhibition of cell growth and induction of apoptotic cell death by the human tumor-associated antigen RCAS1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.06.061

A novel tumor-associated antigen expressed in human uterine and ovarian carcinomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.06.061

Expression and prognostic significance in lung cancer of human tumor-associated antigen RCAS1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.06.061

Expression of tumor-associated antigen RCAS1 correlates significantly with poor prognosis in nonsmall cell lung carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.06.061

RCAS1 expression: a potential prognostic marker for adenocarcinomas of the lung

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.06.061

RCAS1 as a tumour progression marker: an independent negative prognostic factor in gallbladder cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.06.061

RCAS1 expression as a prognostic factor after curative surgery for extrahepatic bile duct carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.06.061

High expression of tumor-associated antigen RCAS1 in pancreatic ductal adenocarcinoma is an unfavorable prognostic marker

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.06.061

The prognostic significance of RCAS1 expression in squamous cell carcinoma of the oesophagus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.06.061

The clinical significance of tumor-associated antigen RCAS1 expression in the normal, hyperplastic, and malignant uterine endometrium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.06.061

Association between RCAS1 expression and clinical outcome in uterine endometrial cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.06.061

Expression of a tumor-associated antigen RCAS1 in hepatocellular carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.06.061

RCAS1 antigen is highly expressed in extramammary Paget's disease and in advanced stage squamous cell carcinoma of the skin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.06.061

EBAG9/RCAS1 in human breast carcinoma: a possible factor in endocrine-immune interactions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.06.061

RCAS1 is associated with ductal breast cancer progression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.06.061

Overexpression of human tumor-associated antigen, RCAS1, is significantly linked to dedifferentiation of thyroid carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.06.061

The use of antiavidin antibody and avidin-biotin-peroxidase complex in immunoperoxidase technics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.06.061

Cleavage of the membrane precursor for transforming growth factor alpha is a regulated process

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.06.061

Phorbol ester induces the rapid processing of cell surface heparin-binding EGF-like growth factor: conversion from juxtacrine to paracrine growth factor activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.06.061

Expression of human tumor-associated antigen RCAS1 in Reed-Sternberg cells in association with Epstein-Barr virus infection: a potential mechanism of immune evasion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.06.061

The Golgi protein RCAS1 controls cell surface expression of tumor-associated O-linked glycan antigens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.06.061

Promoter analysis and chromosomal mapping of human EBAG9 gene.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.06.061

A highly polymorphic CA repeat marker at the EBAG9/RCAS1 locus on 8q23 that detected frequent multiplication in breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.06.061

Genetic deletion and human papillomavirus infection in cervical cancer: loss of heterozygosity sites at 3p and 5p are important genetic events

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.06.061

Chromosome 4 deletions are frequent in invasive cervical cancer and differ between histologic variants.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.06.061

Frequent loss of heterozygosity in chromosomal region 9pter-p13 in tumor biopsies and cytological material of uterine cervical cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.06.061

Loss of heterozygosity at 11q23.3 in vasculoinvasive and metastatic squamous cell carcinoma of the cervix

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.06.061

Loss of heterozygosity in clinical stage IB cervical carcinoma: relationship with clinical and histopathologic features

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.06.061

Expression and diagnostic evaluation of the human tumor-associated antigen RCAS1 in pancreatic cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.06.061

A dual signaling cascade that regulates the ectodomain shedding of heparin-binding epidermal growth factor-like growth factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.06.061

A role for MAP kinase in regulating ectodomain shedding of APLP2 in corneal epithelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.06.061

Mitogen-activated protein kinase-dependent and -independent routes control shedding of transmembrane growth factors through multiple secretases.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.06.061

Involvement of JNK-mediated pathway in EGF-mediated protection against paclitaxel-induced apoptosis in SiHa human cervical cancer cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.06.061

Human papillomaviruses in the pathogenesis of anogenital cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.06.061

Characterization of viral-cellular fusion transcripts in a large series of HPV16 and 18 positive anogenital lesions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.06.061

Localization of deletion to a 300 Kb interval of chromosome 11q13 in cervical cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.06.061

Microsatellite instability is a late event in the carcinogenesis of uterine cervical cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.06.061

Receptor binding cancer antigen expressed on SiSo cells, a novel regulator of apoptosis of erythroid progenitor cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.06.061

A novel mechanism in suppression of erythropoiesis during inflammation: a crucial role of RCAS1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.06.061

Expression of RCAS1 and FasL in human trophoblasts and uterine glands during pregnancy: the possible role in immune privilege

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.06.061

10.1016/J.YGYNO.2005.06.061

7 January 2021

Identifiers

DOI

1 reference

20 September 2017

1 reference